β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We investigated the short- and long-term effects of ceftriaxone on glutamate transporter subtype 1 (GLT-1) transporter activity and extracellular glutamate in the rat nucleus accumbens. Repeated ceftriaxone administration (50, 100 or 200 mg/kg, i.p.) produced a dose-dependent reduction in glutamate levels that persisted for 20 days following discontinuation of drug exposure. The ceftriaxone effect was prevented by the GLT-1 transporter inhibitor dihydrokainate (1 μM, intra-accumbal). These results suggest that β-lactam antibiotics produce an enduring reduction in glutamatergic transmission in the brain reward center.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 11×
“This viewpoint changed in 2005, when a screen of over 1000 clinicallyapproved drugs and nutritionals identified β-lactam antibiotics as the only class of agents capable of increasing GLT-1 transporter activity (Rothstein et al., 2005).”
InfluentialThe glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · cited 1×
“The nucleus accumbens was selected because it is a principal component of the brain reward circuitry that possesses well-defined glutamate systems, which are targeted by abused drugs (Kalivas 2009).”
Miller, B. R., Dorner, J. L., Shou, M., Sari, Y., Barton, S. J., Sengelaub, D. R., Kennedy, R. T., & Rebec, G. V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.004 · Cited by 280 · cited 6×
“Prior studies indicate that brain glutamate levels are elevated in mice lacking GLT-1 transporters and that ceftriaxone reduces glutamate levels 1 day after cessation of drug exposure (Mitani and Tanaka 2003; Miller et al. 2008).”
MethodInfluential
Cited by
Miller, O. H., Yang, L., Wang, C.-C., Hargroder, E. A., Zhang, Y., Delpire, E., & Hall, B. J. (2014) · eLife · doi:10.7554/elife.03581 · Cited by 358
“We pretreated cultures with dl-TBOA, to increase ambient glutamate concentration, or with NDGA or ceftriaxone (24 hr and 1 week, respectively), to enhance EAAT function and decrease ambient glutamate (Rothstein et al., 2005; Rasmussen et al., 2011).”
MethodBisht, R., Kaur, B., Gupta, H., & Prakash, A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.05.009 · Cited by 62
Kelsey, J. E., & Neville, C. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3400-6 · Cited by 30
“Similarly, Rasmussen et al. (2011) found that 5 days of ceftriaxone produced a dose-dependent reduction in extracellular glutamate levels in the n. accumbens that lasted for at least 20 days and was blocked by an injection of the selective GLT-1 antagonist, dihydrokainate (DHK; Pines et al. 1992),…”
BackgroundResultInfluential
Metadata
- Authors
- Rasmussen, B. A., Baron, D. A., Kim, J. K., Unterwald, E. M., & Rawls, S. M.
- Venue
- Amino Acids
- Published
- 2010-04-13
- Volume
- 40
- Issue
- 2
- Pages
- 761-764
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2110325210
- Cited by
- 46
- References
- 3
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. https://app.cochat.ai/papers/10.1007/s00726-010-0589-0
- The paper
- Rasmussen, B. A., Baron, D. A., Kim, J. K., Unterwald, E. M., & Rawls, S. M. (2011). β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats. Amino Acids. https://doi.org/10.1007/s00726-010-0589-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.